General information
Description
To do.
Classifications
| Fontaine | Rutherford | |||
| Stage | Symptoms | Grade | Category | Symptoms |
| I | Asymptomatic | 0 | 0 | Asymptomatic |
| IIa | Non-disabling intermittent claudication > 200m | I | 1 | Mild claudication |
| I | 2 | Moderate claudication | ||
| IIb | Disabling intermittint claudication <200m | I | 3 | Severe claudication |
| III | Ischemic rest pain | II | 4 | Ischemic rest pain |
| IV | Ischemic rest pain + Ulcercation/gangrene | III | 5 | Minor tissue loss |
| III | 6 | Major tissue loss |
Modified after Abojans 2017
Incidence/Prevalence/Age dependency
To do.
Affected vascular beds
To do.
Predominant sex
To do.
Genetics
To do.
Concomitant diseases
To do.
Risk factors
To do.
Geographical variation
[no information available yet]
Differential diagnosis
To do.
Possible complications
To do.
Population screening
Topic of debate.
Symptoms and signs
To do.
Diagnostic procedures
To do.
Treatment/Follow up
General procedure
To do.
Surveillance
STo do.
Medication
[to follow]
Surgery
[to follow]
Treatment complications
[to follow]
Late complications
[to follow]
Prognosis
BibliographyAbojans et al. 2017. ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases [internal]